B.E

Dren Bio Strengthens Leadership Team with Appointment of Amit Mehta, Ph.D., as Chief Operating Officer and Chief Business Officer

Retrieved on: 
Monday, October 30, 2023

Dren Bio, Inc. (“Dren Bio” or the “Company”) a clinical-stage biopharmaceutical company developing antibody therapeutics for cancer, autoimmune and other serious diseases, today announced the expansion of its leadership team with the appointment of Amit Mehta, Ph.D., as the Company’s Chief Operating Officer and Chief Business Officer.

Key Points: 
  • Dren Bio, Inc. (“Dren Bio” or the “Company”) a clinical-stage biopharmaceutical company developing antibody therapeutics for cancer, autoimmune and other serious diseases, today announced the expansion of its leadership team with the appointment of Amit Mehta, Ph.D., as the Company’s Chief Operating Officer and Chief Business Officer.
  • Dr. Mehta will be responsible for business development efforts, corporate strategy and leading the operational advancement and expansion of Dren Bio’s pipeline.
  • During his 18-year tenure at Genentech, Dr. Mehta held roles of increasing responsibility that spanned process development, manufacturing, strategy and business development.
  • “We are thrilled to welcome Amit as the newest member of Dren Bio’s leadership team,” said Nenad Tomasevic, Ph.D., Chief Executive Officer of Dren Bio.

BRADLEY WELCOMES REAL ESTATE ASSOCIATE K. SCOTT SLOAN TO DALLAS OFFICE

Retrieved on: 
Wednesday, July 13, 2022

DALLAS, July 13, 2022 /PRNewswire/ -- Bradley Arant Boult Cummings LLP is pleased to announce the arrival of K. Scott Sloan as an associate in the firm's Dallas office.

Key Points: 
  • DALLAS, July 13, 2022 /PRNewswire/ -- Bradley Arant Boult Cummings LLP is pleased to announce the arrival of K. Scott Sloan as an associate in the firm's Dallas office.
  • "We are pleased to add Scott to the team and know that his experience in the real estate industry will increase our team's capacity to meet the growing needs of our clients," said Bradley Dallas Office Managing Partner Richard A. Sayles .
  • Mr. Sloan is a member of Bradley's Real Estate Practice Group, focusing on real estate acquisitions, dispositions, development, financing and leasing.
  • He is a member of the Texas Real Estate Council and the Dallas Bar Association.

Berkeley Lights Announces Appointment of Dr. Siddhartha Kadia as Chief Executive Officer

Retrieved on: 
Wednesday, March 9, 2022

EMERYVILLE, Calif., March 09, 2022 (GLOBE NEWSWIRE) -- Berkeley Lights, Inc. (Nasdaq: BLI) (Berkeley Lights or the Company) a leader in digital cell biology, today announced it has appointed Dr. Siddhartha Kadia as its new chief executive officer (CEO), effective immediately.

Key Points: 
  • EMERYVILLE, Calif., March 09, 2022 (GLOBE NEWSWIRE) -- Berkeley Lights, Inc. (Nasdaq: BLI) (Berkeley Lights or the Company) a leader in digital cell biology, today announced it has appointed Dr. Siddhartha Kadia as its new chief executive officer (CEO), effective immediately.
  • Dr. Kadia will remain a member of the Berkeley Lights Board of Directors.
  • Siddhartha is an experienced life science executive exceptionally well positioned to lead our company and enhance shareholder value, said Gregory T. Lucier, chairperson of Berkeley Lights Board of Directors.
  • Having joined Berkeley Lights Board last year, Siddhartha is ready to hit the ground running and we expect a seamless transition.

Calfee, Halter & Griswold LLP Elects Patrick Hayes and Brad Liu to Partner

Retrieved on: 
Wednesday, January 5, 2022

Cleveland, Jan. 05, 2022 (GLOBE NEWSWIRE) -- Calfee, Halter & Griswold LLP is pleased to announce that Patrick D. Hayes , attorney with the firm's Corprate and Finance group and Yizhou (Brad) Liu , attorney with the firm's Intellectual Property group have been elected Partners.

Key Points: 
  • Cleveland, Jan. 05, 2022 (GLOBE NEWSWIRE) -- Calfee, Halter & Griswold LLP is pleased to announce that Patrick D. Hayes , attorney with the firm's Corprate and Finance group and Yizhou (Brad) Liu , attorney with the firm's Intellectual Property group have been elected Partners.
  • "Patrick is an incredibly talented lawyer with keen knowledge and insight, and his business acumen and leadership inspire confidence in clients and colleagues alike."
  • Hayes designed the podcast as a personal master class for the securities industrys legal and compliance professionals.
  • Liu has first-hand experience before both the U.S. Patent and Trademark Office (USPTO) and the National Intellectual Property Administration of China (CNIPA).

Bolt Biotherapeutics Announces Changes to its Board of Directors

Retrieved on: 
Friday, November 19, 2021

We are eager to benefit from his knowledge as we make patient-focused decisions to expand our pipeline, said Randall Schatzman, Ph.D., CEO of Bolt Biotherapeutics.

Key Points: 
  • We are eager to benefit from his knowledge as we make patient-focused decisions to expand our pipeline, said Randall Schatzman, Ph.D., CEO of Bolt Biotherapeutics.
  • Mr. OCallaghan also serves on the board of several privately held biotechnology companies, including Indaptus Therapeutics, Aquavit Therapeutics and Biocom Purchasing Group.
  • Bolt has formed a robust pipeline of immune-stimulating, myeloid-engaging therapeutics with the goal of offering long-term tumor remissions for patients.
  • I am excited to help the Bolt Biotherapeutics drive patient-focused decisions that could advance and grow the companys pipeline of product candidates.

Agios Appoints Richa Poddar as Chief Commercial Officer

Retrieved on: 
Monday, November 15, 2021

CAMBRIDGE, Mass., Nov. 15, 2021 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (NASDAQ: AGIO), a leader in the field of cellular metabolism to treat genetically defined diseases, today announced the appointment of Richa Poddar to the role of chief commercial officer, effective Dec. 6, 2021.

Key Points: 
  • CAMBRIDGE, Mass., Nov. 15, 2021 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (NASDAQ: AGIO), a leader in the field of cellular metabolism to treat genetically defined diseases, today announced the appointment of Richa Poddar to the role of chief commercial officer, effective Dec. 6, 2021.
  • Ms. Poddar will replace Darrin Miles, who currently serves as the companys chief commercial officer and has been with Agios since 2015.
  • Miles will depart the company to pursue a chief executive officer role at a private biotechnology company.
  • I look forward to more great things from her as our new chief commercial officer.

Berkeley Lights Announces Appointment of Dr. Siddhartha Kadia to the Board of Directors

Retrieved on: 
Thursday, September 9, 2021

EMERYVILLE, Calif., Sept. 09, 2021 (GLOBE NEWSWIRE) -- Berkeley Lights, Inc. (Nasdaq: BLI), a leader in digital cell biology, today announced that Siddhartha Kadia, Ph.D. joined the Berkeley Lights Board of Directors as an independent director, effective September 7, 2021.

Key Points: 
  • EMERYVILLE, Calif., Sept. 09, 2021 (GLOBE NEWSWIRE) -- Berkeley Lights, Inc. (Nasdaq: BLI), a leader in digital cell biology, today announced that Siddhartha Kadia, Ph.D. joined the Berkeley Lights Board of Directors as an independent director, effective September 7, 2021.
  • I am excited to join the Berkeley Lights Board of Directors," said Dr. Kadia.
  • "Siddhartha brings to Berkeley Lights extensive global leadership experience, both as a CEO and as a public company director, and I am very pleased to welcome him to our Board, said Eric Hobbs, Ph.D., chief executive officer of Berkeley Lights.
  • The Berkeley Lights Platform and the Berkeley Lights Beacon and Lightning systems and Culture Station instrument are FOR RESEARCH USE ONLY.